No Data
No Data
Henlius Biotech H Shares Trading Halted
Fu Hong Hanlin (02696.HK) suspended trading for a short time this morning
Gelonghui May 23 丨 Fu Hong Han Lin (02696.HK) announced that the company's H shares will temporarily stop trading at 9:00 a.m. today (23/5/2024).
Shanghai Henlius Biotech, Inc.'s (HKG:2696) Low P/S No Reason For Excitement
With a price-to-sales (or "P/S") ratio of 1.8x Shanghai Henlius Biotech, Inc. (HKG:2696) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in Hong
Henlius Biotech Gets China Approval for New Indications of Arthritis Drug
Shanghai Henlius Biotech's (HKG:2696) supplemental applications for new indications of Handayuan (adalimumab injection) have been approved by China's National Medical Products Administration. The supp
Henlius Biotech Amends License Deals With Palleon for Bifunctional Protein Products
Shanghai Henlius Biotech (HKG:2696) amended a 2022 license agreement with Palleon Pharmaceuticals for two of Palleon's bifunctional fusion protein products, according to a Tuesday filing with the Hong
Henlius Biotech Expands HANDAYUAN Indications
No Data